Hypertension in metabolic syndrome: Vascular pathophysiology

International Journal of Hypertension

Volumn 2013, Issue , 2013, Pages

  Mendizábal, Yolanda ^a   Llorens, Silvia ^a   Nava, Eduardo ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ENDOTHELIN 1; GLITAZONE DERIVATIVE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN; PROTEIN KINASE B;

ADIPOSE TISSUE; BLOOD VESSEL FUNCTION; CAPILLARY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE; VASCULAR DISEASE; VASODILATATION; ZUCKER DIABETIC FATTY RAT;

EID: 84876567794     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2013/230868     Document Type: Review

References (189)

1. Reaven G. M., Role of insulin resistance in human disease. Diabetes 1988 37 12 1595 1607 2-s2.0-0024160877 (Pubitemid 19004941)
2. Yki-Järvinen H., Utriainen T., Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 1998 41 4 369 379 2-s2.0-0031920445 10.1007/s001250050919 (Pubitemid 28157407)
3. Garrison R. J., Kannel W. B., Stokes J. III, Castelli W. P., Incidence and precursors of hypertension in young adults: the Framingham offspring study. Preventive Medicine 1987 16 2 235 251 2-s2.0-0023204243 (Pubitemid 17067798)
4. Alexander J., Dustan H. P., Sims E. A. H., Tarazi R., Report of the Hypertension Task Force 1979 Washington, DC, USA US Government Printing Office US Department of Health, Education, and Welfare Publication No. 70-1631 (NIH)
5. Tuck M. L., Sowers J., Dornfeld L., The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. The New England Journal of Medicine 1981 304 16 930 933 2-s2.0-0019424146 (Pubitemid 11101080)
6. Reisin E., Abel R., Modan M., Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. The New England Journal of Medicine 1978 298 1 1 6 2-s2.0-0017853234 (Pubitemid 8256364)
7. Berchtold P., Joergens V., Finke C., Berger M., Epidemiology of obesity and hypertension. International Journal of Obesity 1981 5 supplement 1 1 7 2-s2.0-0019829175 (Pubitemid 11090047)
8. Kylin E., Hypertonie and zuckerkrankheit. Zentralblatt für Innere Medizin 1921 42 873 877
9. Marañón G., Über hypertonie and zuckerkrankheit. Zentralblatt für Innere Medizin 1922 43 169 176
10. Kaplan N. M., The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Archives of Internal Medicine 1989 149 7 1514 1520 2-s2.0-0024391834 (Pubitemid 19177621)
11. Zimmet P., Alberti K. G. M. M., Shaw J., Global and societal implications of the diabetes epidemic. Nature 2001 414 6865 782 787 2-s2.0-0035856920 10.1038/414782a (Pubitemid 34000780)
12. Turtle J. R., The economic burden of insulin resistance. International Journal of Clinical Practice 2000 113 23 28 2-s2.0-0033645219
13. Uemura K., Pisa Z., Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Statistics Quarterly 1988 41 3-4 155 178 2-s2.0-0024268112 (Pubitemid 19034357)
14. Critser G., Fat Land: How Americans Became the Fattest People in the World 2004 Mariner Books
15. Rowe J. W., Young J. B., Minaker K. L., Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981 30 3 219 225 2-s2.0-0019483909 (Pubitemid 11026317)
16. Lembo G., Napoli R., Capaldo B., Rendina V., Iaccarino G., Volpe M., Trimarco B., Sacca L., Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. The Journal of Clinical Investigation 1992 90 1 24 29 2-s2.0-0026637065
17. Ter Maaten J. C., Voorburg A., Heine R. J., Ter Wee P. M., Donker A. J. M., Gans R. O. B., Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clinical Science 1997 92 1 51 58 2-s2.0-0031019420 (Pubitemid 27033010)
18. Vierhapper H., Effect of exogenous insulin on blood pressure regulation in healthy and diabetic subjects. Hypertension 1985 7 6, part 2 II49 II53 2-s2.0-0022379579
19. Hall J. E., Mechanisms of abnormal renal sodium handling in obesity hypertension. American Journal of Hypertension 1997 10 5, part 2 49S 55S 2-s2.0-0030923725 (Pubitemid 27239831)
20. Carlyle M., Jones O. B., Kuo J. J., Hall J. E., Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002 39 2 496 501 2-s2.0-0036179086 10.1161/hy0202.104398 (Pubitemid 34165172)
21. Eikelis N., Schlaich M., Aggarwal A., Kaye D., Esler M., Interactions between leptin and the human sympathetic nervous system. Hypertension 2003 41 5 1072 1079 2-s2.0-0038334588 10.1161/01.HYP.0000066289.17754.49 (Pubitemid 36548605)
22. Marsh A. J., Fontes M. A. P., Killinger S., Pawlak D. B., Polson J. W., Dampney R. A. L., Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 2003 42 4 488 493 2-s2.0-0141997258 10.1161/01.HYP.0000090097.22678.0A (Pubitemid 37237343)
23. Alvarez G. E., Beske S. D., Ballard T. P., Davy K. P., Sympathetic neural activation in visceral obesity. Circulation 2002 106 20 2533 2536 2-s2.0-0037069321 10.1161/01.CIR.0000041244.79165.25 (Pubitemid 35340687)
24. Himsworth H. P., Diabetes mellitus. its differentiation into insulin-sensitive and insulin-insensitive types. The Lancet 1936 227 5864 127 130 2-s2.0-50249216083
25. Himsworth H. P., Kerr R., Insulin-sensitive and insulin-insensitive diabetes mellitus. Clinical Science 1939 4 199 152
26. Lebovitz H. E., Insulin resistance: definition and consequences. Experimental and Clinical Endocrinology and Diabetes 2001 109 supplement 2 S135 S148 2-s2.0-0034973768 10.1055/s-2001-18576 (Pubitemid 32577577)
27. Arcaro G., Zamboni M., Rossi L., Turcato E., Covi G., Armellini F., Bosello O., Lechi A., Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. International Journal of Obesity and Related Metabolic Disorders 1999 23 9 936 942 2-s2.0-0032867409 (Pubitemid 29423936)
28. Steinberg H. O., Chaker H., Leaming R., Johnson A., Brechtel G., Baron A. D., Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. The Journal of Clinical Investigation 1996 97 11 2601 2610 2-s2.0-0029977757
29. Tarkun I., Arslan B. C., Cantürk Z., Türemen E., Şahin T., Duman C., Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. Journal of Clinical Endocrinology and Metabolism 2004 89 11 5592 5596 2-s2.0-8744310157 10.1210/jc.2004-0751 (Pubitemid 39518445)
30. Muniyappa R., Montagnani M., Koh K. K., Quon M. J., Cardiovascular actions of insulin. Endocrine Reviews 2007 28 5 463 491 2-s2.0-34547750833 10.1210/er.2007-0006 (Pubitemid 47236334)
31. King G. L., Johnson S. M., Receptor-mediated transport of insulin across endothelial cells. Science 1985 227 4694 1583 1586 2-s2.0-0021907605 (Pubitemid 15119466)
32. Scherrer U., Randin D., Vollenweider P., Vollenweider L., Nicod P., Nitric oxide release accounts for insulin's vascular effects in humans. The Journal of Clinical Investigation 1994 94 6 2511 2515 2-s2.0-0028113927 (Pubitemid 24379629)
33. Steinberg H. O., Brechtel G., Johnson A., Fineberg N., Baron A. D., Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. The Journal of Clinical Investigation 1994 94 3 1172 1179 2-s2.0-0028030813
34. Govers R., Rabelink T. J., Cellular regulation of endothelial nitric oxide synthase. American Journal of Physiology 2001 280 2 F193 F206 2-s2.0-0035018871
35. Kashyap S. R., Roman L. J., Lamont J., Masters B. S. S., Bajaj M., Suraamornkul S., Belfort R., Berria R., Kellogg D. L., Liu Y., DeFronzo R. A., Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. Journal of Clinical Endocrinology and Metabolism 2005 90 2 1100 1105 2-s2.0-20044395441 10.1210/jc.2004-0745 (Pubitemid 40279240)
36. Calver A., Collier J., Vallance P., Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. The Journal of Clinical Investigation 1992 90 6 2548 2554 2-s2.0-0027089884 (Pubitemid 23010077)
37. De Jongh R. T., Serné E. H., Ijzerman R. G., De Vries G., Stehouwer C. D. A., Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004 109 21 2529 2535 2-s2.0-2642572617 10.1161/01.CIR.0000129772. 26647.6F (Pubitemid 38720552)
38. Gudbjörnsdottir S., Elam M., Sellgren J., Anderson E. A., Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives. Journal of Hypertension 1996 14 1 91 97 2-s2.0-0029933363 (Pubitemid 26099522)
39. Schroeder C. A., Chen Y. L., Messina E. J., Inhibition of NO synthesis or endothelium removal reveals a vasoconstrictor effect of insulin on isolated arterioles. American Journal of Physiology 1999 276 3 H815 H820 2-s2.0-0345471473 (Pubitemid 29157452)
40. Shankar R. R., Wu Y., Shen H. Q., Zhu J. S., Baron A. D., Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 2000 49 5 684 687 2-s2.0-0013054309 (Pubitemid 30339980)
41. Nava E., Llorens S., Mendizabal Y., Holcroft R., Vascular function in diabetes mellitus. Treatment Strategies-Diabetes 2010 2 Cambridge Research Centre 209 225
42. 1179 Journal of Biological Chemistry 2001 276 32 30392 30398 2-s2.0-0035839532 10.1074/jbc.M103702200
43. Oliver F. J., De la Rubia G., Feener E. P., Lee M. E., Loeken M. R., Shiba T., Quertermous T., King G. L., Stimulation of endothelin-1 gene expression by insulin in endothelial cells. Journal of Biological Chemistry 1991 266 34 23251 23256 2-s2.0-0026325881 (Pubitemid 21908786)
44. Wolpert H. A., Steen S. N., Istfan N. W., Simonson D. C., Insulin modulates circulating endothelin-1 levels in humans. Metabolism 1993 42 8 1027 1030 2-s2.0-0027166203 10.1016/0026-0495(93)90018-J (Pubitemid 23230436)
45. Ferri C., Pittoni V., Piccoli A., Laurenti O., Cassone M. R., Bellini C., Properzi G., Valesini G., De Mattia G., Santucci A., Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. Journal of Clinical Endocrinology and Metabolism 1995 80 3 829 835 2-s2.0-0028968456 10.1210/jc.80.3.829
46. Cardillo C., Nambi S. S., Kilcoyne C. M., Choucair W. K., Katz A., Quon M. J., Panza J. A., Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999 100 8 820 825 2-s2.0-0033600542 (Pubitemid 29398879)
47. Eringa E. C., Stehouwer C. D. A., Merlijn T., Westerhof N., Sipkema P., Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Cardiovascular Research 2002 56 3 464 471 2-s2.0-0036889823 10.1016/S0008-6363(02)00593-X (Pubitemid 35351568)
48. Verma S., Yao L., Stewart D. J., Dumont A. S., Anderson T. J., McNeill J. H., Endothelin antagonism uncovers insulin-mediated vasorelaxation in vitro and in vivo. Hypertension 2001 37 2 328 333 2-s2.0-0035090489 (Pubitemid 32199095)
49. Tesauro M., Iantorno M., Schinzari F., Cardillo C., Vascular effects of insulin and their relation to endothelial dysfunction, insulin resistance and hypertension. Current Hypertension Reviews 2009 5 4 251 261 2-s2.0-73449083079 10.2174/157340209789587744
50. Taylor P. D., Poston L., The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. British Journal of Pharmacology 1994 113 3 801 808 2-s2.0-0028151070 (Pubitemid 24326818)
51. Bohlen H. G., Lash J. M., Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. American Journal of Physiology 1993 265 1, part 2 H219 H225 2-s2.0-0027293302 (Pubitemid 23224713)
52. Taylor P. D., McCarthy A. L., Thomas C. R., Poston L., Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. British Journal of Pharmacology 1992 107 2 393 399 2-s2.0-0026760160
53. Akbari C. M., Saouaf R., Barnhill D. F., Newman P. A., LoGerfo F. W., Veves A., Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. Journal of Vascular Surgery 1998 28 4 687 694 2-s2.0-0031725229 10.1016/S0741-5214(98) 70095-3 (Pubitemid 28481224)
54. +) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. Journal of Physiology 1996 490 3 775 781 2-s2.0-0029670597
55. Renaudin C., Michoud E., Rapin J. R., Lagarde M., Wiernsperger N., Hyperglycaemia modifies the reaction of microvessels to insulin in rat skeletal muscle. Diabetologia 1998 41 1 26 33 2-s2.0-0031930522 10.1007/s001250050862 (Pubitemid 28105737)
56. Modan M., Halkin H., Almog S., Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. The Journal of Clinical Investigation 1985 75 3 809 817 2-s2.0-0021928204 (Pubitemid 15111002)
57. Ferrannini E., Buzzigoli G., Bonadonna R., Insulin resistance in essential hypertension. The New England Journal of Medicine 1987 317 6 350 357 2-s2.0-0023191508 (Pubitemid 17118813)
58. Landin K., Tengborn L., Smith U., Treating insulin resistance inhypertension with metformin reduces both blood pressure and metabolic risk factors. Journal of Internal Medicine 1991 229 2 181 187 2-s2.0-0026029277
59. Ogihara T., Rakugi H., Ikegami H., Mikami H., Masuo K., Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. American Journal of Hypertension 1995 8 3 316 320 2-s2.0-0028901028 10.1016/0895-7061(95)96214-5
60. Martens F. M. A. C., Visseren F. L. J., Lemay J., De Koning E. J. P., Rabelink T. J., Metabolic and additional vascular effects of thiazolidinediones. Drugs 2002 62 10 1463 1480 2-s2.0-0036076907 (Pubitemid 34804155)
61. Sanchez R. A., Masnatta L. D., Pesiney C., Fischer P., Ramirez A. J., Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives. Journal of Hypertension 2008 26 12 2393 2398 2-s2.0-59849093833 10.1097/HJH.0b013e328312677e
62. Umeda M., Kanda T., Murakami M., Effects of angiotensin II receptor antagonists on insulin resistance syndrome and leptin in sucrose-fed spontaneously hypertensive rats. Hypertension Research 2003 26 6 485 492 2-s2.0-0038301844 10.1291/hypres.26.485 (Pubitemid 36849730)
63. Hall J. E., Summers R. L., Brands M. W., Keen H., Alonso-Galicia M., Resistance to metabolic actions of insulin and its role in hypertension. American Journal of Hypertension 1994 7 8 772 788 2-s2.0-0027959223 (Pubitemid 24269768)
64. Cook K. S., Min H. Y., Johnson D., Chaplinsky R. J., Flier J. S., Hunt C. R., Spiegelman B. M., Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 1987 237 4813 402 405 2-s2.0-0023663615
65. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- α: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
66. Funahashi T., Nakamura T., Shimomura I., Maeda K., Kuriyama H., Takahashi M., Arita Y., Kihara S., Matsuzawa Y., Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Internal Medicine 1999 38 2 202 206 2-s2.0-0033071540
67. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M., Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 6505 425 432 2-s2.0-0028139089 10.1038/372425a0 (Pubitemid 24365442)
68. Trayhurn P., Wood I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004 92 3 347 355 2-s2.0-6944237757 10.1079/BJN20041213 (Pubitemid 40277057)
69. 2 production by rat adipose tissue. Diabetes 1989 38 9 1123 1132 2-s2.0-0024448939 (Pubitemid 19250398)
70. Matsuzawa Y., The metabolic syndrome and adipocytokines. FEBS Letters 2006 580 12 2917 2921 2-s2.0-33646572904 10.1016/j.febslet.2006.04.028 (Pubitemid 43729162)
71. Soltis E. E., Cassis L. A., Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clinical and Experimental Hypertension A 1991 13 2 277 296 2-s2.0-0025855222
72. González M. C., Arribas S. M., Molero F., Fernández-Alfonso M. S., Effect of removal of adventitia on vascular smooth muscle contraction and relaxation. American Journal of Physiology 2001 280 6 H2876 H2881 2-s2.0-0034979563
73. Gao Y. J., Takemori K., Su L. Y., An W. S., Lu C., Sharma A. M., Lee R. M. K. W., Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovascular Research 2006 71 2 363 373 2-s2.0-33745187337 10.1016/j.cardiores.2006.03.013
74. Rey F. E., Li X. C., Carretero O. A., Garvin J. L., Pagano P. J., Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation role of gp91phox. Circulation 2002 106 19 2497 2502 2-s2.0-0037027485 10.1161/01.CIR.0000038108.71560.70 (Pubitemid 35278808)
75. Löhn M., Dubrovska G., Lauterbach B., Luft F. C., Gollasch M., Sharma A. M., Periadventitial fat releases a vascular relaxing factor. The FASEB Journal 2002 16 9 1057 1063 2-s2.0-0036317960 10.1096/fj.02-0024com (Pubitemid 34753512)
76. Verlohren S., Dubrovska G., Tsang S. Y., Essin K., Luft F. C., Huang Y., Gollasch M., Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004 44 3 271 276 2-s2.0-4444224867 10.1161/01.HYP.0000140058.28994.ec (Pubitemid 39167221)
77. Maenhaut N., Van deVoorde J., Regulation of vascular tone by adipocytes. BMC Medicine 2011 9, article 25 10.1186/1741-7015-9-25
78. Gao Y. J., Lu C., Su L. Y., Sharma A. M., Lee R. M. K. W., Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. British Journal of Pharmacology 2007 151 3 323 331 2-s2.0-34249709524 10.1038/sj.bjp.0707228 (Pubitemid 46842669)
79. Gao Y. J., Zeng Z. H., Teoh K., Sharma A. M., Abouzahr L., Cybulsky I., Lamy A., Semelhago L., Lee R. M. K. W., Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. Journal of Thoracic and Cardiovascular Surgery 2005 130 4 1130 1136 2-s2.0-26444574129 10.1016/j.jtcvs.2005.05.028 (Pubitemid 41427351)
80. Schleifenbaum J., Köhn C., Voblova N., Dubrovska G., Zavarirskaya O., Gloe T., Crean C. S., Luft F. C., Huang Y., Schubert R., Gollasch M., Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide. Journal of Hypertension 2010 28 9 1875 1882 2-s2.0-77955853941 10.1097/HJH.0b013e32833c20d5
81. Sierra-Honigmann M. R., Nath A. K., Murakami C., García- Cardeña G., Papapetropoulos A., Sessa W. C., Madge L. A., Schechner J. S., Schwabb M. B., Polverini P. J., Flores-Riveros J. R., Biological action of leptin as an angiogenic factor. Science 1998 281 5383 1683 1686 2-s2.0-0032508682 10.1126/science.281.5383.1683 (Pubitemid 28435586)
82. Winters B., Mo Z., Brooks-Asplund E., Kim S., Shoukas A., Li D., Nyhan D., Berkowitz D. E., Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. Journal of Applied Physiology 2000 89 6 2382 2390 2-s2.0-0033672015
83. Shirasaka T., Takasaki M., Kannan H., Cardiovascular effects of leptin and orexins. American Journal of Physiology 2003 284 3 R639 R651 2-s2.0-0037343052 (Pubitemid 36342796)
84. Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., Mckee L. J., Bauer T. L., Caro J. F., Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 1996 334 5 292 295 2-s2.0-13344295079 10.1056/NEJM199602013340503 (Pubitemid 26033933)
85. Frühbeck G., Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999 48 4 903 908 2-s2.0-0037907471 (Pubitemid 29153093)
86. Knudson J. D., Dincer U. D., Zhang C., Swafford A. N., Koshida R., Picchi A., Focardi M., Dick G. M., Tune J. D., Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. American Journal of Physiology 2005 289 1 H48 H56 2-s2.0-21644438084 10.1152/ajpheart.01159.2004 (Pubitemid 40934081)
87. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M. L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001 7 8 941 946 2-s2.0-17944365228 10.1038/90984 (Pubitemid 32756432)
88. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B. B., Kadowaki T., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002 8 11 1288 1295 2-s2.0-0036851817 10.1038/nm788 (Pubitemid 35373562)
89. Kondo H., Shimomura L., Matsukawa Y., Kumada M., Takahashi M., Matsuda M., Ouchi N., Kihara S., Kawamoto T., Sumitsuji S., Funahashi T., Matsuzawa Y., Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002 51 7 2325 2328 2-s2.0-0036303146 (Pubitemid 34729044)
90. Takahashi M., Funahashi T., Shimomura I., Miyaoka K., Matsuzawa Y., Plasma leptin levels and body fat distribution. Hormone and Metabolic Research 1996 28 12 751 752 2-s2.0-0030455366 (Pubitemid 27057931)
91. Asayama K., Hayashibe H., Dobashi K., Uchida N., Nakane T., Kodera K., Shirahata A., Taniyama M., Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obesity Research 2003 11 9 1072 1079 2-s2.0-1542495700 (Pubitemid 41151584)
92. Xi W., Satoh H., Kase H., Suzuki K., Hattori Y., Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochemical and Biophysical Research Communications 2005 332 1 200 205 2-s2.0-19344367253 10.1016/j.bbrc.2005.04.111 (Pubitemid 40719474)
93. Fésüs G., Dubrovska G., Gorzelniak K., Kluge R., Huang Y., Luft F. C., Gollasch M., Adiponectin is a novel humoral vasodilator. Cardiovascular Research 2007 75 4 719 727 2-s2.0-34547828786 10.1016/j.cardiores.2007.05.025 (Pubitemid 47243720)
94. Greenstein A. S., Khavandi K., Withers S. B., Sonoyama K., Clancy O., Jeziorska M., Laing I., Yates A. P., Pemberton P. W., Malik R. A., Heagerty A. M., Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009 119 12 1661 1670 2-s2.0-65249102725 10.1161/CIRCULATIONAHA.108.821181
95. Lindsay R. S., Funahashi T., Hanson R. L., Matsuzawa Y., Tanaka S., Tataranni P. A., Knowler W. C., Krakoff J., Adiponectin and development of type 2 diabetes in the Pima Indian population. The Lancet 2002 360 9326 57 58 2-s2.0-0037031088 10.1016/S0140-6736(02)09335-2 (Pubitemid 34756495)
96. Stefan N., Vozarova B., Funahashi T., Matsuzawa Y., Weyer C., Lindsay R. S., Youngren J. F., Havel P. J., Pratley R. E., Bogardus C., Antonio Tataranni P., Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002 51 6 1884 1888 2-s2.0-0036266897 (Pubitemid 34564302)
97. Mallamaci F., Zoccali C., Cuzzola F., Tripepi G., Cutrupi S., Parlongo S., Tanaka S., Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Adiponectin in essential hypertension. Journal of Nephrology 2002 15 5 507 511 2-s2.0-0036760026 (Pubitemid 35396514)
98. Uysal K. T., Wiesbrock S. M., Marino M. W., Hotamisligil G. S., Protection from obesity-induced insulin resistance in mice lacking TNF- α function. Nature 1997 389 6651 610 614 2-s2.0-0030756346 10.1038/39335 (Pubitemid 27446179)
99. Bastard J. P., Maachi M., Lagathu C., Kim M. J., Caron M., Vidal H., Capeau J., Feve B., Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network 2006 17 1 4 12 2-s2.0-33745896155
100. Richelsen B., Borglum J. D., Sorensen S. S., Biosynthetic capacity and regulatory aspects of prostaglandin E2 formation in adipocytes. Molecular and Cellular Endocrinology 1992 85 1-2 73 81 2-s2.0-0026606087
101. Fain J. N., Leffler C. W., Cowan G. S. M. Jr., Buffington C., Pouncey L., Bahouth S. W., Stimulation of leptin release by arachidonic acid and prostaglandin E2 in adipose tissue from obese humans. Metabolism 2001 50 8 921 928 2-s2.0-0034876184 10.1053/meta.2001.24927 (Pubitemid 32755009)
102. Kim J. A., Montagnani M., Koh K. K., Quon M. J., Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006 113 15 1888 1904 2-s2.0-33646178955 10.1161/CIRCULATIONAHA.105.563213 (Pubitemid 43739401)
103. Engeli S., Schling P., Gorzelniak K., Boschmann M., Janke J., Ailhaud G., Teboul M., Massiéra F., Sharma A. M., The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? International Journal of Biochemistry and Cell Biology 2003 35 6 807 825 2-s2.0-0037409237 10.1016/S1357-2725(02)00311-4 (Pubitemid 36379323)
104. Boustany C. M., Bharadwaj K., Daugherty A., Brown D. R., Randall D. C., Cassis L. A., Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. American Journal of Physiology 2004 287 4 R943 R949 2-s2.0-4644307190 10.1152/ajpregu.00265.2004 (Pubitemid 39280483)
105. Gálvez-Prieto B., Bolbrinker J., Stucchi P., de las Heras A. I., Merino B., Arribas S., Ruiz-Gayo M., Huber M., Wehland M., Kreutz R., Fernandez-Alfonso M. S., Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. Journal of Endocrinology 2008 197 1 55 64 2-s2.0-42449095968 10.1677/JOE-07-0284 (Pubitemid 351566925)
106. Briones A. M., Nguyen Dinh Cat A., Callera G. E., Adipocytes produce aldosterone through calcineurin-dependent signaling pathways. Hypertension 2012 59 5 1069 1078
107. Frederich R. C. Jr., Kahn B. B., Peach M. J., Flier J. S., Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992 19 4 339 344 2-s2.0-0026740639
108. Rahmouni K., Mark A. L., Haynes W. G., Sigmund C. D., Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity. American Journal of Physiology 2004 286 6 E891 E895 2-s2.0-2442646800 10.1152/ajpendo.00551.2003 (Pubitemid 38668809)
109. Goodfriend T. L., Calhoun D. A., Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 2004 43 3 518 524 2-s2.0-1442338287 10.1161/01.HYP.0000116223.97436.e5 (Pubitemid 38282420)
110. Ehrhart-Bornstein M., Lamounier-Zepter V., Schraven A., Langenbach J., Willenberg H. S., Barthel A., Hauner H., McCann S. M., Scherbaum W. A., Bornstein S. R., Human adipocytes secrete mineralocorticoid-releasing factors. Proceedings of the National Academy of Sciences of the United States of America 2003 100 2 14211 14216 2-s2.0-10744220710 10.1073/pnas.2336140100 (Pubitemid 37499216)
111. Krug A. W., Ehrhart-Bornstein M., Newly discovered endocrine functions of white adipose tissue: possible relevance in obesity-related diseases. Cellular and Molecular Life Sciences 2005 62 12 1359 1362 2-s2.0-20744456715 10.1007/s00018-005-4555-z (Pubitemid 40853823)
112. Connell J. M. C., Davies E., The new biology of aldosterone. Journal of Endocrinology 2005 186 1 1 20 2-s2.0-22544466731 10.1677/joe.1.06017 (Pubitemid 41015660)
113. Rocchini A. P., Moorehead C., DeRemer S., Goodfriend T. L., Ball D. L., Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 1990 15 6, part 2 861 866 2-s2.0-0025335474 (Pubitemid 20189470)
114. Petrasek D., Jensen G., Tuck M., Stern N., In vitro effects of insulin on aldosterone production in rat zona glomerulosa cells. Life Sciences 1992 50 23 1781 1787 2-s2.0-0026506195 10.1016/0024-3205(92)90062-T
115. Fain J. N., Tagele B. M., Cheema P., Madan A. K., Tichansky D. S., Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women. Obesity 2010 18 5 890 896 2-s2.0-77951667090 10.1038/oby.2009.335
116. Morise T., Takeuchi Y., Kawano M., Koni I., Takeda R., Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 1995 18 1 87 89 2-s2.0-0028843125
117. Da Silva A. A., Kuo J. J., Tallam L. S., Hall J. E., Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension 2004 43 2 383 387 2-s2.0-0842289892 10.1161/01.HYP.0000111139.94378.74 (Pubitemid 38174143)
118. Barton M., Carmona R., Ortmann J., Krieger J. E., Traupe T., Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. International Journal of Biochemistry and Cell Biology 2003 35 6 826 837 2-s2.0-0037409319 10.1016/S1357-2725(02)00307-2 (Pubitemid 36379324)
119. Van Harmelen V., Eriksson A., Åström G., Wåhlén K., Näslund E., Karpe F., Frayn K., Olsson T., Andersson J., Rydén M., Arner P., Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis. Diabetes 2008 57 2 378 386 2-s2.0-40749132624 10.2337/db07-0893
120. Zucker L. M., Zucker T. F., Fatty, a new mutation in the rat. Journal of Heredity 1961 52 6 275 278 2-s2.0-77957216320
121. Chua S. C. Jr., Chung W. K., Wu-Peng X. S., Zhang Y., Liu S. M., Tartaglia L., Leibel R. L., Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996 271 5251 994 996 2-s2.0-0030028959 (Pubitemid 26066874)
122. Phillips M. S., Liu Q., Hammond H. A., Dugan V., Hey P. J., Caskey C. J., Hess J. F., Leptin receptor missense mutation in the fatty Zucker rat. Nature Genetics 1996 13 1 18 19 2-s2.0-0030137757
123. Bray G. A., The Zucker fatty rat: a review. Federation Proceedings 1977 36 2 148 153 2-s2.0-0017347635 (Pubitemid 8039862)
124. Alonso-Galicia M., Brands M. W., Zappe D. H., Hall J. E., Hypertension in obese Zucker rats: role of angiotensin II and adrenergic activity. Hypertension 1996 28 6 1047 1054 2-s2.0-0029808766 (Pubitemid 26415823)
125. Landsberg L., Krieger D. R., Obesity, metabolism, and the sympathetic nervous system. American Journal of Hypertension 1989 2 3, part 2 125S 132S 2-s2.0-0024523219 (Pubitemid 19082352)
126. Aleixandre A., Miguel M., Experimental rat models to study the metabolic syndrome. British Journal of Nutrition 2009 102 9 1246 1253 2-s2.0-73349118496 10.1017/S0007114509990729
127. Auguet M., Delaflotte S., Braquet P., Increased influence of endothelium in obese zucker rat aorta. Journal of Pharmacy and Pharmacology 1989 41 12 861 864 2-s2.0-0024949709 (Pubitemid 20112153)
128. Cox R. H., Kikta D. C., Age-related changes in thoracic aorta of obese Zucker rats. American Journal of Physiology 1992 262 5, part 2 H1548 H1556 2-s2.0-0026652720
129. Sexl V., Mancusi G., Raberger G., Schutz W., Age-related changes in vascular reactivity in genetically diabetic rats. Pharmacology 1995 50 4 238 246 2-s2.0-0028919935
130. Andrews T. J., Laicht D. W., Änggård E. E., Carrier M. J., Investigation of endothelial hyperreactivity in the obese Zucker rat in-situ: reversal by vitamin E. Journal of Pharmacy and Pharmacology 2000 52 1 83 86 2-s2.0-0034048725 (Pubitemid 30125287)
131. Laight D. W., Änggård E. E., Carrier M. J., Investigation of basal endothelial function in the obese Zucker rat in vitro. General Pharmacology 2000 35 6 303 309 2-s2.0-0141628766 10.1016/S0306-3623(01)00120-3 (Pubitemid 34258512)
132. Bohlen H. G., Lash J. M., Endothelial-dependent vasodilation is preserved in non-insulin-dependent Zucker fatty diabetic rats. American Journal of Physiology 1995 268 6, part 2 H2366 H2374 2-s2.0-0029033444
133. Frisbee J. C., Stepp D. W., Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. American Journal of Physiology 2001 281 3 H1304 H1311 2-s2.0-0034836663
134. Xiang L., Naik J. S., Hodnett B. L., Hester R. L., Altered arachidonic acid metabolism impairs functional vasodilation in metabolic syndrome. American Journal of Physiology 2006 290 1 R134 R138 2-s2.0-33644840160 10.1152/ajpregu.00295.2005
135. Xiang L., Dearman J., Abram S. R., Carter C., Hester R. L., Insulin resistance and impaired functional vasodilation in obese Zucker rats. American Journal of Physiology 2008 294 4 H1658 H1666 2-s2.0-41749118516 10.1152/ajpheart.01206.2007 (Pubitemid 351490596)
136. Goodwill A. G., James M. E., Frisbee J. C., Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension. American Journal of Physiology 2008 295 4 H1522 H1528 2-s2.0-57049186709 10.1152/ajpheart.00596.2008
137. Frisbee J. C., Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. American Journal of Physiology 2005 289 2 R307 R316 2-s2.0-23044449830 10.1152/ajpregu.00114.2005 (Pubitemid 41060480)
138. Ernsberger P., Koletsky R. J., Friedman J. E., Molecular pathology in the
139. Takaya K., Ogawa Y., Hiraoka J., Hosoda K., Yamori Y., Nakao K., Koletsky R. J., Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nature Genetics 1996 14 2 130 131 2-s2.0-0030267744
140. Hiraoka J., Hosoda K., Ogawa Y., Ikeda K., Nara Y., Masuzaki H., Takaya K., Nakagawa K., Mashimo T., Sawamura M., Koletsky R. J., Yamori Y., Nakao K., Augmentation of obese (ob) gene expression and leptin secretion in obese spontaneously hypertensive rats (Obese SHR or Koletsky rats). Biochemical and Biophysical Research Communications 1997 231 3 582 585 2-s2.0-0031584837 10.1006/bbrc.1997.6145 (Pubitemid 27217557)
141. Koletsky S., Obese spontaneously hypertensive rats: a model for study of atherosclerosis. Experimental and Molecular Pathology 1973 19 1 53 60 2-s2.0-0015891045
142. Huang S. S., Khosrof S. A., Koletsky R. J., Benetz B. A., Ernsberger P., Characterization of retinal vascular abnormalities in lean and obese spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology 1995 22 1 S129 S131 2-s2.0-0029560966 (Pubitemid 26062059)
143. Ernsberger P., Koletsky R. J., Baskin J. S., Foley M., Refeeding hypertension in obese spontaneously hypertensive rats. Hypertension 1994 24 6 699 705 2-s2.0-0028004330 (Pubitemid 24363966)
144. Ernsberger P., Koletsky R. J., Collins L. A., Douglas J. G., Renal angiotensin receptor mapping in obese spontaneously hypertensive rats. Hypertension 1993 21 6, part 2 1039 1045 2-s2.0-0027316031 (Pubitemid 23166964)
145. Mendizábal Y., Llorens S., Nava E., Reactivity of the aorta and mesenteric resistance arteries from the obese spontaneously hypertensive rat: effects of glitazones. American Journal of Physiology 2011 301 4 H1319 H1330
146. O'Brien S. F., McKendrick J. D., Radomski M. W., Davidge S. T., Russell J. C., Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance. Canadian Journal of Physiology and Pharmacology 1998 76 1 72 76 2-s2.0-0031918438 10.1139/cjpp-76-1-72 (Pubitemid 28201101)
147. Boustany-Kari C. M., Gong M., Akers W. S., Guo Z., Cassis L. A., Enhanced vascular contractility and diminished coronary artery flow in rats made hypertensive from diet-induced obesity. International Journal of Obesity 2007 31 11 1652 1659 2-s2.0-35648981980 10.1038/sj.ijo.0803426 (Pubitemid 350023149)
148. Dobrian A. D., Davies M. J., Schriver S. D., Lauterio T. J., Prewitt R. L., Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 2001 37 2, part 2 554 560 2-s2.0-0035090072 (Pubitemid 32199027)
149. Jebelovszki E., Kiraly C., Erdei N., Feher A., Pasztor E. T., Rutkai I., Forster T., Edes I., Koller A., Bagi Z., High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation. American Journal of Physiology 2008 294 6 H2558 H2564 2-s2.0-49249134335 10.1152/ajpheart.01198.2007
150. Haddock R. E., Grayson T. H., Morris M. J., Howitt L., Chadha P. S., Sandow S. L., Diet-induced obesity impairs endothelium-derived hyperpolarization via altered potassium channel signaling mechanisms. PLoS ONE 2011 6 1 2-s2.0-79251633164 10.1371/journal.pone.0016423 e16423
151. Naderali E. K., Pickavance L. C., Wilding J. P. H., Williams G., Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weight. Clinical Science 2001 100 6 635 641 2-s2.0-0034995828 10.1042/CS20000279 (Pubitemid 32523316)
152. Gil-Ortega M., Stucchi P., Guzmán-Ruiz R., Cano V., Arribas S., González M. C., Ruiz-Gayo M., Fernández-Alfonso M. S., Somoza B., Adaptative nitric oxide overproduction in perivascular adipose tissue during early diet-induced obesity. Endocrinology 2010 151 7 3299 3306 2-s2.0-77954588212 10.1210/en.2009-1464
153. Nilsson C., Raun K., Yan F. F., Larsen M. O., Tang-Christensen M., Laboratory animals as surrogate models of human obesity. Acta Pharmacologica Sinica 2012 33 2 173 181
154. Mavri A., Poredoš P., Šuran D., Gaborit B., Juhan-Vague I., Poredoš P., Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting. Heart and Vessels 2011 26 1 31 38 2-s2.0-79151474227 10.1007/s00380-010-0016-1
155. Chatterjee T. K., Stoll L. L., Denning G. M., Harrelson A., Blomkalns A. L., Idelman G., Rothenberg F. G., Neltner B., Romig-Martin S. A., Dickson E. W., Rudich S., Weintraub N. L., Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circulation Research 2009 104 4 541 549 2-s2.0-61949318555 10.1161/CIRCRESAHA.108.182998
156. Donato A. J., Henson G. D., Morgan R. G., Enz R. A., Walker A. E., Lesniewski L. A., TNF-alpha impairs endothelial function in adipose tissue resistance arteries of mice with diet-induced obesity. American Journal of Physiology 2012 303 6 H672 H679
157. Ketonen J., Shi J., Martonen E., Mervaala E., Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57BL/6 mice. Circulation Journal 2010 74 7 1479 1487 2-s2.0-77954512283 10.1253/circj.CJ-09-0661
158. Elizalde M., Rydén M., Van Harmelen V., Eneroth P., Gyllenhammar H., Holm C., Ramel S., Ölund A., Arner P., Andersson K., Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. Journal of Lipid Research 2000 41 8 1244 1251 2-s2.0-0033847418 (Pubitemid 30666890)
159. Ma L., Ma S., He H., Yang D., Chen X., Luo Z., Liu D., Zhu Z., Perivascular fat-mediated vascular dysfunction and remodeling through the AMPK/mTOR pathway in high-fat diet-induced obese rats. Hypertension Research 2010 33 5 446 453 2-s2.0-77951971550 10.1038/hr.2010.11
160. Kimura K., Tsuda K., Baba A., Kawabe T., Boh-Oka S. I., Ibata M., Moriwaki C., Hano T., Nishio I., Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochemical and Biophysical Research Communications 2000 273 2 745 749 2-s2.0-0033873205 10.1006/bbrc.2000.3005 (Pubitemid 30599054)
161. Lembo G., Vecchione C., Fratta L., Marino G., Trimarco V., D'Amati G., Trimarco B., Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000 49 2 293 297 2-s2.0-0033978467 (Pubitemid 30071008)
162. Vecchione C., Maffei A., Colella S., Aretini A., Poulet R., Frati G., Gentile M. T., Fratta L., Trimarco V., Trimarco B., Lembo G., Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002 51 1 168 173 2-s2.0-0036091969 (Pubitemid 34517994)
163. Matsuda K., Teragawa H., Fukuda Y., Nakagawa K., Higashi Y., Chayama K., Leptin causes nitric-oxide independent coronary artery vasolidation in humans. Hypertension Research 2003 26 2 147 152 2-s2.0-0037301213 10.1291/hypres.26.147 (Pubitemid 36372333)
164. Momin A. U., Melikian N., Shah A. M., Grieve D. J., Wheatcroft S. B., John L., El Gamel A., Desai J. B., Nelson T., Driver C., Sherwood R. A., Kearney M. T., Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. European Heart Journal 2006 27 19 2294 2299 2-s2.0-33749001704 10.1093/eurheartj/ehi831 (Pubitemid 44453572)
165. Fortuño A., Rodríguez A., Gómez-Ambrosi J., Muñiz P., Salvador J., Díez J., Frühbeck G., Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology 2002 143 9 3555 3560 2-s2.0-0036721247 10.1210/en.2002-220075 (Pubitemid 34925731)
166. Gentile M. T., Vecchione C., Marino G., Aretini A., Pardo A. D., Antenucci G., Maffei A., Cifelli G., Iorio L., Landolfl A., Frati G., Lembo G., Resistin impairs insulin-evoked vasodilation. Diabetes 2008 57 3 577 583 2-s2.0-40949126146 10.2337/db07-0557
167. Chen C., Jiang J., Lü J. M., Chai H., Wang X., Lin P. H., Yao Q., Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. American Journal of Physiology 2010 299 1 H193 H201 2-s2.0-77953788470 10.1152/ajpheart.00431.2009
168. Xi W., Satoh H., Kase H., Suzuki K., Hattori Y., Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochemical and Biophysical Research Communications 2005 332 1 200 205 2-s2.0-19344367253 10.1016/j.bbrc.2005.04.111 (Pubitemid 40719474)
169. Yamawaki H., Hara N., Okada M., Hara Y., Visfatin causes endothelium-dependent relaxation in isolated blood vessels. Biochemical and Biophysical Research Communications 2009 383 4 503 508 2-s2.0-65449181941 10.1016/j.bbrc.2009.04.074
170. Varma V., Yao-Borengasser A., Rasouli N., Bodles A. M., Phanavanh B., Lee M. J., Starks T., Kern L. M., Spencer H. J., McGehee R. E., Fried S. K., Kern P. A., Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. Journal of Clinical Endocrinology and Metabolism 2007 92 2 666 672 2-s2.0-33846991610 10.1210/jc.2006-1303
171. Yang C. C., Deng S. J., Hsu C. C., Liu B. H., Lin E. C., Cheng W. T. K., Wang P. H., Ding S. T., Visfatin regulates genes related to lipid metabolism in porcine adipocytes. Journal of Animal Science 2010 88 10 3233 3241 2-s2.0-77957226193 10.2527/jas.2010-2799
172. Zhang H., Park Y., Wu J., Chen X. P., Lee S., Yang J., Dellsperger K. C., Zhang C., Role of TNF- α in vascular dysfunction. Clinical Science 2009 116 3 219 230 2-s2.0-60549098432 10.1042/CS20080196
173. Hector J., Schwarzloh B., Goehring J., Strate T. C., Hess U. F., Deuretzbacher C., Hansen-Algenstaedt N., Beil F. U., Algenstaedt P., TNF- α alters visfatin and adiponectin levels in human fat. Hormone and Metabolic Research 2007 39 4 250 255 2-s2.0-34248218011 10.1055/s-2007-973075 (Pubitemid 46715881)
174. Zhang D. X., Yi F. X., Zou A. P., Li P. L., Role of ceramide in TNF- α -induced impairment of endothelium-dependent vasorelaxation in coronary arteries. American Journal of Physiology 2002 283 5 H1785 H1794 2-s2.0-0036838876 (Pubitemid 35217011)
175. Brian J. E., Faraci F. M., Tumor necrosis factor- α -induced dilatation of cerebral arterioles. Stroke 1998 29 2 509 515 2-s2.0-0031908071 (Pubitemid 28086699)
176. Johns D. G., Webb R. C., TNF- α -induced endothelium-independent vasodilation: a role for phospholipase A2-dependent ceramide signaling. American Journal of Physiology 1998 275 5 H1592 H1598 2-s2.0-0031755713
177. Wort S. J., Ito M., Chou P. C., Mc Master S. K., Badiger R., Jazrawi E., de Souza P., Evans T. W., Mitchell J. A., Pinhu L., Ito K., Adcock I. M., Synergistic induction of endothelin-1 by tumor necrosis factor α and interferon γ is due to enhanced NF- B binding and histone acetylation at specific B sites. Journal of Biological Chemistry 2009 284 36 24297 24305 2-s2.0-69949159203 10.1074/jbc.M109.032524
178. Brasier A. R., Li J., Wimbish K. A., Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 1996 27 4 1009 1017 2-s2.0-0029863473 (Pubitemid 26113850)
179. Ohkawa F., Ikeda U., Kawasaki K., Kusano E., Igarashi M., Shimada K., Inhibitory effect of interleukin-6 on vascular smooth muscle contraction. American Journal of Physiology 1994 266 3 H898 H902 2-s2.0-0028052774
180. Minghini A., Britt L. D., Hill M. A., Interleukin-1 and interleukin-6 mediated skeletal muscle arteriolar vasodilation: in vitro versus in vivo studies. Shock 1998 9 3 210 215 2-s2.0-0032013336 (Pubitemid 128463287)
181. Schrader L. I., Kinzenbaw D. A., Johnson A. W., Faraci F. M., Didion S. P., IL-6 deficiency protects against angiotensin II-induced endothelial dysfunction and hypertrophy. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 12 2576 2581 2-s2.0-36349024339 10.1161/ATVBAHA.107.153080 (Pubitemid 350158908)
182. Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance. The Journal of Clinical Investigation 2006 116 7 1793 1801 2-s2.0-33745861300 10.1172/JCI29069
183. Moncada S., Adventures in vascular biology: a tale of two mediators. Philosophical Transactions of the Royal Society B 2006 361 1469 735 759 2-s2.0-33845236186 10.1098/rstb.2005.1775 (Pubitemid 44858917)
184. Feletou M., Huang Y., Vanhoutte P. M., Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. British Journal of Pharmacology 2011 164 3 894 912
185. Zhang C., Hein T. W., Wang W., Kuo L., Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circulation Research 2003 92 3 322 329 2-s2.0-0037458932 10.1161/01.RES.0000056759.53828.2C (Pubitemid 36258555)
186. Mehta P. K., Griendling K. K., Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. American Journal of Physiology 2007 292 1 C82 C97 2-s2.0-33846362954 10.1152/ajpcell. 00287.2006 (Pubitemid 46127306)
187. Taddei S., Virdis A., Ghiadoni L., Salvetti A., Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide. Journal of Cardiovascular Pharmacology 2000 35 S37 S40 2-s2.0-0033646549 10.1097/00005344-200000002-00009
188. 2+ sensitization. Free Radical Biology and Medicine 2009 46 5 633 642 2-s2.0-59249090538 10.1016/j.freeradbiomed.2008.11.015
189. Gryglewski R. J., Palmer R. M. J., Moncada S., Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986 320 6061 454 456 2-s2.0-0022640297 (Pubitemid 16097810)